161 related articles for article (PubMed ID: 17354109)
1. Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.
Van Blankenstein M; Looman CW; Kruijshaar ME; Siersema PD; Kuipers EJ; Bytzer P
Scand J Gastroenterol; 2007 Mar; 42(3):308-17. PubMed ID: 17354109
[TBL] [Abstract][Full Text] [Related]
2. The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference.
van Blankenstein M; Looman CW; Hop WC; Bytzer P
Am J Gastroenterol; 2005 Apr; 100(4):766-74. PubMed ID: 15784017
[TBL] [Abstract][Full Text] [Related]
3. Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports.
Post PN; Siersema PD; Van Dekken H
Scand J Gastroenterol; 2007 Jan; 42(1):17-22. PubMed ID: 17190757
[TBL] [Abstract][Full Text] [Related]
4. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
5. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
6. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.
Desai TK; Krishnan K; Samala N; Singh J; Cluley J; Perla S; Howden CW
Gut; 2012 Jul; 61(7):970-6. PubMed ID: 21997553
[TBL] [Abstract][Full Text] [Related]
7. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
8. Meta analysis: Cancer risk in Barrett's oesophagus.
Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
[TBL] [Abstract][Full Text] [Related]
9. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D
Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of Barrett's oesophagus in the general population.
van Soest EM; Dieleman JP; Siersema PD; Sturkenboom MC; Kuipers EJ
Gut; 2005 Aug; 54(8):1062-6. PubMed ID: 15857935
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma.
Guardino JM; Khandwala F; Lopez R; Wachsberger DM; Richter JE; Falk GW
Am J Gastroenterol; 2006 Oct; 101(10):2187-93. PubMed ID: 17032182
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Barrett's esophagus.
Cameron AJ
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D3-4. PubMed ID: 8013779
[No Abstract] [Full Text] [Related]
13. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.
Walther C; Zilling T; Perfekt R; Möller T
Eur J Surg; 2001 Oct; 167(10):748-57. PubMed ID: 11775726
[TBL] [Abstract][Full Text] [Related]
14. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
[TBL] [Abstract][Full Text] [Related]
15. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Barrett's oesophagus: a population-based approach.
Johansson J; Håkansson HO; Mellblom L; Kempas A; Johansson KE; Granath F; Nyrén O
Scand J Gastroenterol; 2007 Feb; 42(2):148-56. PubMed ID: 17327933
[TBL] [Abstract][Full Text] [Related]
17. The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.
Masclee GM; Coloma PM; de Wilde M; Kuipers EJ; Sturkenboom MC
Aliment Pharmacol Ther; 2014 Jun; 39(11):1321-30. PubMed ID: 24738722
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?
Lagergren J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i1-5. PubMed ID: 15711002
[TBL] [Abstract][Full Text] [Related]
19. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
